2015
DOI: 10.1016/j.nut.2014.12.024
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of metabolically healthy obese Brazilians and cardiovascular risk prediction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
14
0

Year Published

2016
2016
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(15 citation statements)
references
References 32 publications
1
14
0
Order By: Relevance
“…In the current study, the presence of IR was defined as above the upper quartile of the distribution of the calculated HOMA index among nondiabetic subjects. The definition was also widely used in most studies focusing on IR and diabetes [34, 35]. In our study, the proportions of IR in MHO defined by BMI in combination with ATPIII, Karelis, Wildman, or CDS were 30.5, 16.5, 22.5, and 30.6%, respectively.…”
Section: Discussionmentioning
confidence: 51%
“…In the current study, the presence of IR was defined as above the upper quartile of the distribution of the calculated HOMA index among nondiabetic subjects. The definition was also widely used in most studies focusing on IR and diabetes [34, 35]. In our study, the proportions of IR in MHO defined by BMI in combination with ATPIII, Karelis, Wildman, or CDS were 30.5, 16.5, 22.5, and 30.6%, respectively.…”
Section: Discussionmentioning
confidence: 51%
“…To evaluate cardiovascular risk, Pimentel et al [55] applied the well validated Framingham Risk Score (FRS) in a Brazilian population, and found that there was some indication that metabolically unhealthy obese patients were at increased cardiovascular risk as compared to MHO patients. However, this was specifically noted to hold true when ATP III criteria (alone or in conjunction with HOMA), but not with HOMA model alone [55].…”
Section: Metabolic Outcomesmentioning
confidence: 99%
“…However, this was specifically noted to hold true when ATP III criteria (alone or in conjunction with HOMA), but not with HOMA model alone [55]. This was in opposition to data gleaned from the London based Whitehall II cohort, which showed decreased when development of T2DM in MHO patients, but also demonstrated an increased risk of cardiovascular disease compared to their metabolically unhealthy counterparts [56].…”
Section: Metabolic Outcomesmentioning
confidence: 99%
“…After that, several studies also published their results with large sample size, [ 13 15 ] especially for the investigations conducted in Cameroon, Australia, and Brazil. [ 16 18 ] Additionally, no meta-analysis has been conducted on the transition from MHO to MAO status based on available evidence. There is still no convincing evidence regarding the effects of interventions on the metabolic profile for MHO subjects as well.…”
Section: Introductionmentioning
confidence: 99%